Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction

Pulmonary hypertension (PH) conveys a worse prognosis in heart failure (HF), in particular when right ventricular (RV) dysfunction ensues. Cardiovascular magnetic resonance (CMR) non-invasively estimates pulmonary vascular resistance (PVR), which has shown prognostic value in HF. Importantly, RV to...

Descripción completa

Detalles Bibliográficos
Autores: Trejo-Velasco, Blanca, Fabregat Andrés, Óscar, García-González, Pilar M., Perdomo-Londoño, Diana C., Cubillos-Arango, Andrés M., Ferrando-Beltrán, Mónica I., Belchi-Navarro, Joaquina, Pérez-Boscá, José L., Payá-Serrano, Rafael, Ridocci-Soriano, Francisco
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Universidad Católica de Valencia San Vicente Mártir
Repositorio:RIUCV. Repositorio de la Universidad Católica de Valencia San Vicente Mártir
Idioma:inglés
OAI Identifier:oai:riucv.ucv.es:20.500.12466/6959
Acceso en línea:https://hdl.handle.net/20.500.12466/6959
Access Level:acceso abierto
Palabra clave:HFrEF
Cardiac MRI
Right ventricle
Ventricular-arterial coupling
Prognosis
Pulmonary hypertension
32 Ciencias Médicas
Descripción
Sumario:Pulmonary hypertension (PH) conveys a worse prognosis in heart failure (HF), in particular when right ventricular (RV) dysfunction ensues. Cardiovascular magnetic resonance (CMR) non-invasively estimates pulmonary vascular resistance (PVR), which has shown prognostic value in HF. Importantly, RV to pulmonary artery (PA) coupling is altered early in HF, before significant rise in PV resistance occurs. The aim of this study was to assess the prognostic value of mean velocity at the pulmonary artery (mvPA), a novel non-invasive parameter determined by CMR, in HF with reduced ejection fraction (HFrEF) with and without associated PH.

Similares en LA Referencia